Details of the Drug

General Information of Drug (ID: DMQ8R1A)

• Drug Name: APG-157

Indication

Disease Entry	ICD 11	Status	REF
Oral cavity squamous cell carcinoma	2B6E.0	Phase 2	[1]

• Cross-matching ID:
  DrugBank ID: DB18683
  TTD ID: DMOG46

References

• [1] ClinicalTrials.gov (NCT05312710) Phase 2 Study to Evaluate the Safety and Efficacy of APG-157 as Neoadjuvant/Induction Therapy for Patients With Head and Neck Squamous Cell Cancer (HNSCC) of the Oral Cavity and/or Oropharynx. U.S.National Institutes of Health.